Hirawat Samit
Pacira BioSciences, Inc. · Director
Hirawat Samit is listed in filings as Director at Pacira BioSciences, Inc.. This profile follows SEC Form 4 activity through Jun 12, 2026, including purchase activity. Recent filings connect the profile to Pacira BioSciences, Inc. (PCRX) and Bristol-Myers Squibb Co (BMY). The current snapshot covers public activity from Apr 29, 2025 to Jun 12, 2026. Reported amounts are shown as $255.1K to $202.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $202k4.3k shares | BuyApr 25, 2025 | $47.58 | $60.85 |